Stock Screener

Stock Screener · Library

CERO THERAPEUTICS HOLDINGS, INC. financial statement history

Source-linked financial facts for CERO THERAPEUTICS HOLDINGS, INC. with exact reported periods, units and filing dates. Historical periods ending 2021–2025.

What this record covers

This historical reference uses a locally cached SEC companyfacts snapshot and reports periods ending from 2021 through 2025. It is not a current quotation feed, a screening recommendation or a verification of the company's present condition.

Each value retains its reported unit and exact period. Filing fiscal year describes the submitting filing and can differ from the year of a comparative fact. Values with different currencies or period boundaries are not combined.

Total assets

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-31180078207USD2023-03-242022 / FYus-gaap:Assets10-K · 0001193125-23-078172
As of 2022-12-3142367032USD2024-04-022023 / FYus-gaap:Assets10-K · 0001213900-24-029051
As of 2023-12-315126302USD2025-04-152024 / FYus-gaap:Assets10-K · 0001213900-25-032134
As of 2024-12-316206929USD2026-04-152025 / FYus-gaap:Assets10-K · 0001213900-26-044040
As of 2025-12-313641134USD2026-04-152025 / FYus-gaap:Assets10-K · 0001213900-26-044040

Current assets

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-311361073USD2023-03-242022 / FYus-gaap:AssetsCurrent10-K · 0001193125-23-078172
As of 2022-12-3142367032USD2023-03-242022 / FYus-gaap:AssetsCurrent10-K · 0001193125-23-078172
As of 2023-12-311970035USD2025-04-152024 / FYus-gaap:AssetsCurrent10-K · 0001213900-25-032134
As of 2024-12-313714041USD2026-04-152025 / FYus-gaap:AssetsCurrent10-K · 0001213900-26-044040
As of 2025-12-312734280USD2026-04-152025 / FYus-gaap:AssetsCurrent10-K · 0001213900-26-044040

Cash and cash equivalents

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-06-070USD2022-03-242021 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001193125-22-083868
As of 2021-12-311098573USD2023-03-242022 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001193125-23-078172
As of 2022-12-31475870USD2024-04-022023 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001213900-24-029051
As of 2023-12-3196873USD2024-04-022023 / FYus-gaap:CashAndCashEquivalentsAtCarryingValue10-K · 0001213900-24-029051
As of 2024-12-313327060USD2026-04-152025 / FYus-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents10-K · 0001213900-26-044040
As of 2025-12-311662380USD2026-04-152025 / FYus-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents10-K · 0001213900-26-044040

Property, plant and equipment

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2023-12-31966702USD2025-04-152024 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001213900-25-032134
As of 2024-12-31528521USD2026-04-152025 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001213900-26-044040
As of 2025-12-31246148USD2026-04-152025 / FYus-gaap:PropertyPlantAndEquipmentNet10-K · 0001213900-26-044040

Total liabilities

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-319248072USD2023-03-242022 / FYus-gaap:Liabilities10-K · 0001193125-23-078172
As of 2022-12-3139898341USD2024-04-022023 / FYus-gaap:Liabilities10-K · 0001213900-24-029051
As of 2023-12-315082653USD2025-04-152024 / FYus-gaap:Liabilities10-K · 0001213900-25-032134
As of 2024-12-318101492USD2026-04-152025 / FYus-gaap:Liabilities10-K · 0001213900-26-044040
As of 2025-12-319087596USD2026-04-152025 / FYus-gaap:Liabilities10-K · 0001213900-26-044040

Current liabilities

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-12-3198072USD2023-03-242022 / FYus-gaap:LiabilitiesCurrent10-K · 0001193125-23-078172
As of 2022-12-3130748341USD2024-04-022023 / FYus-gaap:LiabilitiesCurrent10-K · 0001213900-24-029051
As of 2023-12-313507154USD2025-04-152024 / FYus-gaap:LiabilitiesCurrent10-K · 0001213900-25-032134
As of 2024-12-317402385USD2026-04-152025 / FYus-gaap:LiabilitiesCurrent10-K · 0001213900-26-044040
As of 2025-12-319087596USD2026-04-152025 / FYus-gaap:LiabilitiesCurrent10-K · 0001213900-26-044040

Stockholders equity

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
As of 2021-06-070USD2023-03-242022 / FYus-gaap:StockholdersEquity10-K · 0001193125-23-078172
As of 2021-12-31-7669865USD2024-04-022023 / FYus-gaap:StockholdersEquity10-K · 0001213900-24-029051
As of 2022-12-31-11000154USD2024-04-022023 / FYus-gaap:StockholdersEquity10-K · 0001213900-24-029051
As of 2023-12-31-42057695USD2025-04-152024 / FYus-gaap:StockholdersEquity10-K · 0001213900-25-032134
As of 2024-02-14-2347903USD2026-04-152025 / FYus-gaap:StockholdersEquity10-K · 0001213900-26-044040
As of 2024-12-31-1894563USD2026-04-152025 / FYus-gaap:StockholdersEquity10-K · 0001213900-26-044040
As of 2025-12-31-5446462USD2026-04-152025 / FYus-gaap:StockholdersEquity10-K · 0001213900-26-044040

Research and development

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2023-01-01 to 2023-12-315288580USD2025-04-152024 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001213900-25-032134
2024-02-14 to 2024-12-316315552USD2025-04-152024 / FYus-gaap:ResearchAndDevelopmentExpense10-K · 0001213900-25-032134

Operating income

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2022-01-01 to 2022-12-31-2905441USD2024-04-022023 / FYus-gaap:OperatingIncomeLoss10-K · 0001213900-24-029051
2023-01-01 to 2023-12-31-7675049USD2025-04-152024 / FYus-gaap:OperatingIncomeLoss10-K · 0001213900-25-032134
2024-02-14 to 2024-12-31-15300903USD2025-04-152024 / FYus-gaap:OperatingIncomeLoss10-K · 0001213900-25-032134

Net income

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2022-01-01 to 2022-12-31-667736USD2024-04-022023 / FYus-gaap:NetIncomeLoss10-K · 0001213900-24-029051
2023-01-01 to 2023-12-31-7289577USD2025-04-152024 / FYus-gaap:NetIncomeLoss10-K · 0001213900-25-032134
2024-02-14 to 2024-12-31-7732212USD2025-04-152024 / FYus-gaap:NetIncomeLoss10-K · 0001213900-25-032134
2025-01-01 to 2025-12-31-19920262USD2026-04-152025 / FYus-gaap:NetIncomeLoss10-K · 0001213900-26-044040

Diluted earnings per share

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2023-01-01 to 2023-12-31-1248.64USD/shares2025-04-152024 / FYus-gaap:EarningsPerShareDiluted10-K · 0001213900-25-032134
2024-02-14 to 2024-12-31-18.15USD/shares2025-04-152024 / FYus-gaap:EarningsPerShareDiluted10-K · 0001213900-25-032134

Operating cash flow

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2022-01-01 to 2022-12-31-1092247USD2024-04-022023 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001213900-24-029051
2023-01-01 to 2023-12-31-1523604USD2024-04-022023 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001213900-24-029051
2025-01-01 to 2025-12-31-16100000USD2026-04-152025 / FYus-gaap:NetCashProvidedByUsedInOperatingActivities10-K · 0001213900-26-044040

Dividends paid

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2025-01-01 to 2025-12-31127144USD2026-04-152025 / FYus-gaap:PaymentsOfDividends10-K · 0001213900-26-044040

Share repurchases

Reported periodValueUnitFiledFiling FY / FPTaxonomy conceptSource filing
2022-01-01 to 2022-12-31139353878USD2024-04-022023 / FYus-gaap:PaymentsForRepurchaseOfCommonStock10-K · 0001213900-24-029051
2023-01-01 to 2023-12-3133481627USD2024-04-022023 / FYus-gaap:PaymentsForRepurchaseOfCommonStock10-K · 0001213900-24-029051

Source and method

SEC public numeric facts are reorganized into a standard reference. Tag priority follows the native app's declared concept chains; the latest filed observation is selected within the same exact start, end and unit. A missing value stays missing. No currency, quarterly total, ratio, share-price series or dividend calendar is inferred.

The ticker below belongs to the native source snapshot. Company names, tickers and reporting structures may change; CIK identifies the source filer.

Source filer CIK
1870404
Ticker in native snapshot
CERO
Reported numeric facts
53
Units present
USD · USD/shares